These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 28715973)

  • 21. Mitotic deacetylase complex (MiDAC) recognizes the HIV-1 core promoter to control activated viral gene expression.
    Wilhelm E; Poirier M; Da Rocha M; Bédard M; McDonald PP; Lavigne P; Hunter CL; Bell B
    PLoS Pathog; 2024 May; 20(5):e1011821. PubMed ID: 38781120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A chalcone derivative reactivates latent HIV-1 transcription through activating P-TEFb and promoting Tat-SEC interaction on viral promoter.
    Wu J; Ao MT; Shao R; Wang HR; Yu D; Fang MJ; Gao X; Wu Z; Zhou Q; Xue YH
    Sci Rep; 2017 Sep; 7(1):10657. PubMed ID: 28878233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TRIM28 promotes HIV-1 latency by SUMOylating CDK9 and inhibiting P-TEFb.
    Ma X; Yang T; Luo Y; Wu L; Jiang Y; Song Z; Pan T; Liu B; Liu G; Liu J; Yu F; He Z; Zhang W; Yang J; Liang L; Guan Y; Zhang X; Li L; Cai W; Tang X; Gao S; Deng K; Zhang H
    Elife; 2019 Jan; 8():. PubMed ID: 30652970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular mechanisms of HIV latency.
    Cary DC; Fujinaga K; Peterlin BM
    J Clin Invest; 2016 Feb; 126(2):448-54. PubMed ID: 26731470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The molecular biology of HIV latency: breaking and restoring the Tat-dependent transcriptional circuit.
    Karn J
    Curr Opin HIV AIDS; 2011 Jan; 6(1):4-11. PubMed ID: 21242887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of HIV latency by epigenetic and non-epigenetic mechanisms.
    Mbonye U; Karn J
    Curr HIV Res; 2011 Dec; 9(8):554-67. PubMed ID: 22211660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression.
    Darcis G; Kula A; Bouchat S; Fujinaga K; Corazza F; Ait-Ammar A; Delacourt N; Melard A; Kabeya K; Vanhulle C; Van Driessche B; Gatot JS; Cherrier T; Pianowski LF; Gama L; Schwartz C; Vila J; Burny A; Clumeck N; Moutschen M; De Wit S; Peterlin BM; Rouzioux C; Rohr O; Van Lint C
    PLoS Pathog; 2015 Jul; 11(7):e1005063. PubMed ID: 26225566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fused in sarcoma silences HIV gene transcription and maintains viral latency through suppressing AFF4 gene activation.
    Krasnopolsky S; Marom L; Victor RA; Kuzmina A; Schwartz JC; Fujinaga K; Taube R
    Retrovirology; 2019 Jun; 16(1):16. PubMed ID: 31238957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interplay between viral Tat protein and c-Jun transcription factor in controlling LTR promoter activity in different human immunodeficiency virus type I subtypes.
    van der Sluis RM; Derking R; Breidel S; Speijer D; Berkhout B; Jeeninga RE
    J Gen Virol; 2014 Apr; 95(Pt 4):968-979. PubMed ID: 24447950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV latency reversing agents act through Tat post translational modifications.
    Khoury G; Mota TM; Li S; Tumpach C; Lee MY; Jacobson J; Harty L; Anderson JL; Lewin SR; Purcell DFJ
    Retrovirology; 2018 May; 15(1):36. PubMed ID: 29751762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long Noncoding RNA uc002yug.2 Activates HIV-1 Latency through Regulation of mRNA Levels of Various RUNX1 Isoforms and Increased Tat Expression.
    Huan C; Li Z; Ning S; Wang H; Yu XF; Zhang W
    J Virol; 2018 May; 92(9):. PubMed ID: 29491162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient Non-Epigenetic Activation of HIV Latency through the T-Cell Receptor Signalosome.
    Hokello J; Sharma AL; Tyagi M
    Viruses; 2020 Aug; 12(8):. PubMed ID: 32784426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New insights into transcription elongation control of HIV-1 latency and rebound.
    Mbonye U; Kizito F; Karn J
    Trends Immunol; 2023 Jan; 44(1):60-71. PubMed ID: 36503686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional profiles of latent human immunodeficiency virus in infected individuals: effects of Tat on the host and reservoir.
    Lin X; Irwin D; Kanazawa S; Huang L; Romeo J; Yen TS; Peterlin BM
    J Virol; 2003 Aug; 77(15):8227-36. PubMed ID: 12857891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Molecular basis of HIV-1 latency - part I: physiology of HIV-1 latency].
    Schwartz C; Le Douce V; Cherrier T; Redel L; Marban C; Aunis D; Rohr O
    Med Sci (Paris); 2010 Feb; 26(2):159-63. PubMed ID: 20188047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lost in transcription: molecular mechanisms that control HIV latency.
    Taube R; Peterlin M
    Viruses; 2013 Mar; 5(3):902-27. PubMed ID: 23518577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Negative elongation factor is required for the maintenance of proviral latency but does not induce promoter-proximal pausing of RNA polymerase II on the HIV long terminal repeat.
    Jadlowsky JK; Wong JY; Graham AC; Dobrowolski C; Devor RL; Adams MD; Fujinaga K; Karn J
    Mol Cell Biol; 2014 Jun; 34(11):1911-28. PubMed ID: 24636995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 latency in actively dividing human T cell lines.
    Jeeninga RE; Westerhout EM; van Gerven ML; Berkhout B
    Retrovirology; 2008 Apr; 5():37. PubMed ID: 18439275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An analog of the natural steroidal alkaloid cortistatin A potently suppresses Tat-dependent HIV transcription.
    Mousseau G; Clementz MA; Bakeman WN; Nagarsheth N; Cameron M; Shi J; Baran P; Fromentin R; Chomont N; Valente ST
    Cell Host Microbe; 2012 Jul; 12(1):97-108. PubMed ID: 22817991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shutdown of HIV-1 Transcription in T Cells by Nullbasic, a Mutant Tat Protein.
    Jin H; Li D; Sivakumaran H; Lor M; Rustanti L; Cloonan N; Wani S; Harrich D
    mBio; 2016 Jul; 7(4):. PubMed ID: 27381288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.